Drug Price Gouging Enforcement in US and Europe
12 PM EST
Steep pharmaceutical price increases are a priority for policymakers on both sides of the Atlantic. European authorities have applied antitrust prohibitions on alleged "excessive pricing” by dominant companies to impose fines over $100 million. Lacking similar US antitrust rules, certain US states, such as Maryland, have introduced pharmaceutical price transparency and anti-pricegouging laws. These provide for notification of price increases exceeding a specified threshold and empower the state to impose civil penalties and enjoin “unconscionable increases”. This panel of US and EU enforcers, including the Maryland AG's office, and practitioners examine how the laws apply in the US and EU.
Bill Batchelor, Baker McKenzie
Lauren Rackow, Cahill Gordon & Reindel LLP
Joshua N. Auerbach, Maryland Attorney General’s office
Paul Csiszar, European Commission, Directorate-General for Competition
Maria Salgado, Cornerstone, San Francisco
Assimakis Komninos, White & Case, Brussels
FREE: Antitrust Section Members, Government, Non-profit Employees, Students, $25.00 Other Non-Members
Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25. For this and all upcoming events visit http://ambar.org/atevents.
The ABA is not seeking CLE credit for this program.
Audio Archive: Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.